Biohaven Ltd. Common Shares (BHVN)
NYSE · Healthcare
$14.86-3.76%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.65B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,784,453
- 52-week high
- —
- 52-week low
- —
- Open
- $15.51
- Day high
- $15.79
- Day low
- $14.75
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$738.82M | -$6.86 |
| 2024 | — | -$846.42M | -$9.28 |
| 2023 | — | -$408.17M | -$5.73 |
| 2022 | — | -$570.28M | -$12.75 |
| 2021 | — | -$213.8M | -$5.43 |
About Biohaven Ltd. Common Shares
Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.
- CEO
- Vladimir Coric
- Employees
- 256
- Country
- US
- IPO date
- Sep 23, 2022
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Biohaven Ltd. Common Shares's stock price today?
- BHVN is trading at $14.86 as of Jul 20, 2026.
- What is Biohaven Ltd. Common Shares's market cap?
- Biohaven Ltd. Common Shares (BHVN) has a market capitalization of $1.65B.
- Does Biohaven Ltd. Common Shares pay a dividend?
- Biohaven Ltd. Common Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is Biohaven Ltd. Common Shares in?
- Biohaven Ltd. Common Shares operates in the Healthcare sector.